博士生导师

首页  师资队伍  博导硕导  博士生导师

朱清

作者:金飞     日期:2023-11-06   点击数:3381  

师资介绍

一般信息:

姓名:朱清                     性别:

出生年月:1978.08             学历:医学博士

职称:教授博士生导师(特种医学研究院)

职务:天然药物与药物分析系主任

邮箱:zhuqing@ntu.edu.cn


教育经历:

2016/7-2017/12,美国,布法罗大学,Jacobs医学和生物医学学院,高级访问学者

2008/9–2012/6, 复旦大学, 药学药理学专业,博士

2001/9–2004/7, 南通医学院航海医学,硕士

1996/9–2001/6, 武汉科技大学, 医学临床医学专业,学士


工作经历

2022/09-至今, 永利集团88304官网集团,永利集团88304官网集团,教授

2014/1-2022/09,永利集团88304官网集团,永利集团88304官网集团,副教授

2007/7-2013/12,永利集团88304官网集团,医学院,讲师

2004/8-2007/6,永利集团88304官网集团,医学院,助教

研究方向:

天然镇痛药物研发;药物动力学以及代谢组学研究


社会兼职:

南通市药学会生物医药产学研与创新工作委员会委员

Frontiers in Pharmacology评审编辑

教育部学位中心博士/硕士研究生论文盲审专家

多种SCI杂志审稿

科研项目:

  1. 国家自然科学基金面上项目,82071238,基于疼痛抑制行为探讨去甲青藤碱靶向α2-GABAA受体的镇痛效应,2021/01-2024/1255万,在研,主持(PI

  2. 江苏省自然科学基金面上项目BK20181459,基于疼痛抑制行为的去甲青藤碱镇痛效应及与GABAA受体相关机制研究,2018/07-2021/0610万,结题,主持(PI

  3. 江苏省自然科学青年基金项目BK20181459,益母草碱抗心肌缺血作用及药效物质基础的代谢组学研究,2013/07-2016/0620万,结题,主持(PI

  4. 国家自然科学基金面上项目,81971243TAAR1-CaMKII-CREB信号通路调节尼古丁成瘾2020/01-2023/1255万,在研,副主持(Co-PI

  5. 国家自然科学基金面上项目,81373390,选择性咪唑啉I2受体配体的镇痛效应及滥用潜力研究,2014/01-2017/1265万元,结题,副主持(Co-PI

  6. 中国博士后自然科学基金面上项目,2016M591898,基于疼痛抑制行为的青藤碱及其代谢物镇痛作用研究2016/05-2019/055万元,结题,主持(PI

代表性论文:

  1. Huixiao Duo, Jiayuan Yue, Xiaodan Zhang, Siqi Li, Yujian Yin, Liyun Wang, Jiejia Li,Weiwei Rong, Andong Wang, Yuan Zhang,Qing Zhu*.Magnetic solid phase extraction based on metal organic framework for pharmaceutical analysis from food, environmental and biological media.Microchem. J.,2024, 196:109557.通讯作者)

  2. Lulu Yu, Xunjia Qian, Yiheng Feng, Yujian Yin, Xiao-Dan Zhang, Qianqian Wei, Liyun Wang, Weiwei Rong, Jie-Jia Li, Jun-Xu Li*,Qing Zhu*. Investigation of preclinical pharmacokinetics of N-demethylsinomenine, a potential novel analgesic candidate, using an UPLC-MS/MS quantification method.Front Chem. 2023,11:1222560. doi: 10.3389/fchem.2023.1222560.通讯作者)

  3. Huixiao Duo*, Jiayuan Yue, Yujian Yin, Xiaoyu Xu, Liyun Wang, Lulu Yu,Xunjia Qian, Jiejia Li,Qing Zhu*.Magnetic carbon nanoparticles derived from Co-based metal-organic frameworks for magnetic solid-phase extraction and determination of phenylurea herbicides.Microchem. J.,2023, 185:108190.通讯作者)

  4. Weiwei Rong, Jiejia Li, Dingyi Pan, Qinbei Zhou, Yexuan Zhang, Qianxing Lu, Liyun Wang,Andong Wang, YizhunZhu*,QingZhu*. Cardioprotective Mechanism of Leonurine against MyocardialIschemia through a Liver–Cardiac CrosstalkMetabolomics Study.Biomolecules, 2022, 12, 1512.通讯作者)

  5. Feifeng Yang, Yue Zhu, Congyu Zhang, Ziyan Yang, Jia Yuan,Qing Zhu*, Shushu Ding*.A highly sensitive and selective artificial nanochannel for in situ detection of hydroxyl radicals in single living cell.Anal. Chim. Acta.,2022 1235:340537通讯作者)

  6. WeiweiRong, JiejiaLi, LifengWang, ShanshanLuo, TuluLiang, XunjiaQian, XiaodanZhang, QinbeiZhou, YizhunZhu*,QingZhu*. Investigation of the protective mechanism of leonurine against acute myocardial ischemia by an integrated metabolomics and network pharmacology strategy.Front. Cardiovasc. Med., 2022, 9: 969553.通讯作者)

  7. Ming-Cong Zheng, Wen-Ting Tang, Lu-Lu Yu, Xun-Jia Qian, Jie Ren, Jie-Jia Li, Wei-Wei Rong,Jun-Xu LiandQing Zhu*.Preclinical Pharmacokinetics andBioavailability of Oxypeucedanin inRats after Single Intravenous andOral Administration.Molecules, 2022,27, 3570.通讯作者)

  8. Xiaohua Pan#,Qing Zhu#, Li-Long Pan*,Jia Sun*. Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy.Pharmacol. & Ther., 2022238: 108176.(共同第一作者)

  9. Zhiyong Zhou, Nanqing Qiu, Yuntao Ou, QianqianWei, WentingTang,MingcongZheng, Yaluan Xing, Jie Jia Li, Yong Ling, Junxu Li* &Qing Zhu*. N Demethylsinomenine, an active metabolite of sinomenine, attenuates chronic neuropathic and infammatory pain in mice.Sci. Rep., 2021, 11:9300.通讯作者)

  10. Yuntao Ou, Man Su, Yong Ling, Qianqian Wei, Fei Pan, Jiejia Li, Jun-Xu Li*,Qing Zhu*. Anti-allodynic effects of N-demethylsinomenine, an active metabolite of sinomenine, in a mouse model of postoperative pain.Eur. J. Pharmacol. 2018, 823:105–109.通讯作者)

  11. Yong Ling, Jing Guo, Qiuxing Yang, Peng Zhu, Jiefei Miao, Weijie Gao, Yanfu Peng, Jiaying Yang, Kun Xu, Biao Xiong, Gongqing Liu, Jinhua Tao, Lin Luo,Qing Zhu*, Yanan Zhang*. Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.Eur. J. Med. Chem., 2018, 144:398-409.通讯作者)

  12. Qing Zhu, Yuehua Sun, Lina Mao, Chengpeng Liu, Bo Jiang, Wei Zhang & Jun-Xu Li. Antinociceptive effects of sinomenine in a rat model of postoperative painBrit. J. Pharmacol., 2016, 173:1693-1702.

  13. Qing Zhu, Li-Na Mao, Cheng-Peng Liu, Yue-Hua Sun, Bo Jiang, Wei Zhang & Jun-Xu Li. Antinociceptive effects of vitexin in a mouse model of postoperative pain.Sci. Rep., 2016, 6:19266.

  14. Qing Zhu, Yuehua Sun, Jie Zhu, Tian Fang, Wei Zhang & Jun-Xu Li. Antinociceptive effects of sinomenine in a rat model of neuropathic pain.Sci. Rep., 2014, 4: 7270.

  15. Qing Zhu, Yuehua Sun, Xiaodi Yun, Yuntao Ou, Wei Zhang & Jun-Xu Li. Antinociceptive effects of curcumin in a rat model of postoperative pain,Sci. Rep., 2014, 4:4932.

  16. Qing Zhu, Jinlian Zhang, Ping Yang, Bo Tan, Xinhua Liu, Yuanting Zheng, Weimin Cai & Yizhun Zhu. Characterization of Metabolites of Leonurine (SCM-198) in Rats after Oral Administration by Liquid Chromatography/Tandem Mass Spectrometry and NMR Spectrometry,Sci. World J., 2014, 2014:947946.

  17. Qing Zhu, Weimin Cai, Xianyi Sha, Guo Ma, Yuanting Zheng, Xueru Shi & Yizhun Zhu. Quantification of leonurine, a novel potential cardiovascular agent, in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study in rats,Biomed. Chromatogr., 2012, 26(4): 518-523.

  18. Jie-Jia Li#,Qing Zhu#, Ya-Peng Lu, Peng Zhao, Zhan-Bo Feng, Zhong-Ming Qian & Li Zhu. Ligustilide prevents cognitive impairment and attenuates neurotoxicity in D-galactose induced aging mice brain,Brain Res., 2015,1595:19-28.(共同第一作者)

  19. Donggeng Wang#,Qing Zhu#, Baohua Liu, Guangtong Chen & Yong Ling. Identification of gut microbial metabolites of a synthetic nitric oxide-releasing farnesylthiosalicylic acid derivative, an antitumor agent,Anal. Lett., 2014, 47(2):191-201.(共同第一作者)

  20. Qing Zhu, Jinhua Gu, Hongyan Zhu & Jiliang Xu. Identification of differentially expressed genes in dorsal root ganglion in early diabetic rats,Neurosci. Bull., 2008, 24(4):219-24.  

授权发明专利

  1. 朱清于陆陆李俊旭钱珣佳郑铭璁王丽云李洁佳定量检测血浆中去甲青藤碱浓度的方法及检测试剂盒2024/01/23中国,ZL202210937262.5

  2. Zhu, Qing, et al. anlagesic drug composition. 2020/12/18, NigeriaNG/PT/C/2020/4763.  

  3. 朱清, 李俊旭, 苏漫, 李洁佳, 欧云淘,一种镇痛药物组合物,2021/03/19

中国,ZL201710671939.4  

  1. 朱清,卫蒨蒨,唐文婷,李俊旭,潘菲,邱男青,周致用,李洁佳, 氧化前胡素的新用途,2020/05/08,中国ZL201810813028.5

  2. 朱清,李俊旭,卫蒨蒨,潘菲,邱男青,李洁佳,氧化前胡素在制备治疗术后疼痛药物中的应用,2020/04/28,中国ZL201810751676.2

  3. 朱清,李俊旭,孙越华,青藤碱在制备治疗慢性疼痛伴抑郁行为药物中的应用,2017/01/04中国,ZL201410456667.2

  4. 李俊旭,朱清,欧云淘,苏漫,赵颖,去甲青藤碱在制备镇痛药物中的应用,2019/12/20中国,ZL201610331233.9

  5. 李俊旭,朱清,毛丽娜,刘成鹏,孙越华,牡荆素在制备治疗术后疼痛中的应用,2017.11.07,中国,ZL201510642790.8


获奖情况:


南通市药学会优秀学术带头人


永利集团88304官网集团“互联网+”大学生创业大赛二等奖(指导教师)


永利集团88304官网集团优秀党务工作者